search
Back to results

Essential Acute Stroke Care in Low Resource Settings: a Pilot studY (EASY)

Primary Purpose

Acute Stroke

Status
Not yet recruiting
Phase
Not Applicable
Locations
International
Study Type
Interventional
Intervention
Acute stroke care Intervention arm
Sponsored by
The George Institute
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Acute Stroke focused on measuring Stroke, Ischemic stroke, hemorrhagic stroke, stroke package

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adults (age ≥18 years)
  • A clinical or imaging-based diagnosis of acute stroke (ischemic or haemorrhagic) within 72 hours of stroke symptom onset
  • Provision of written informed consent
  • Subjects in observational, natural history and/or epidemiological studies not involving an intervention are eligible.

Exclusion Criteria:

  • Patients who have undergone intravenous thrombolysis or mechanical thrombectomy
  • Patients who are planned for transfer to the intensive care unit
  • Subarachnoid haemorrhage
  • Participation in an interventional medical investigation or clinical trial currently or within the past 3 months.

Sites / Locations

  • Murtala Muhammad Specialist Hospital
  • Federal Medical Centre
  • Hospital de Apoyo II-2 Sullana
  • Hospital de la Amistad Peru Corea Santa Rosa II-2

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Other

Arm Label

Usual Care

Intervention arm

Arm Description

Usual care to be provided to patients as per hospital guidelines for 3 months

The intervention consists of training and education of the site staff about the treatment protocol for the different components of the management plan will be provided on two occasions. This intervention will run for 3 months. Refresher training will be given monthly during the intervention.

Outcomes

Primary Outcome Measures

Adherence
Primary Outcome Measure: Adherence to the predefined components of the essential acute stroke care management plan Adherence will be expressed as all or none measure and is defined as the proportion of patients who receive all the components of acute stroke care management for which the patient is eligible. Adherence will also be expressed as a composite measure, which is defined as the total number of eligible components performed divided by the total number of components for which the patient was eligible.

Secondary Outcome Measures

Death or disability
Death or disability as measured by Modified Rankin Scale (mRS) at 30 days. The mRS is a disability scale that ranges from 0 (no symptoms) to 6 (death).

Full Information

First Posted
November 4, 2019
Last Updated
August 2, 2023
Sponsor
The George Institute
Collaborators
World Heart Federation
search

1. Study Identification

Unique Protocol Identification Number
NCT04157231
Brief Title
Essential Acute Stroke Care in Low Resource Settings: a Pilot studY
Acronym
EASY
Official Title
Essential Acute Stroke Care in Low Resource Settings: a Pilot Study
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
October 30, 2024 (Anticipated)
Primary Completion Date
October 30, 2025 (Anticipated)
Study Completion Date
November 30, 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
The George Institute
Collaborators
World Heart Federation

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
An investigator-initiated, evaluator-blinded, prospective, multi centre, before-and-after, effectiveness-implementation hybrid design study to assess the feasibility of essential acute stroke care in a low resource setting
Detailed Description
This is a multicentre, before and after, effectiveness-implementation hybrid study design with blinded outcome assessment. Patients admitted to the participating hospitals will be managed under usual care conditions for three months (control arm). This will be followed by the training of the doctors and nurses in those hospitals on essential acute stroke care management. Patient management for the following three months after the training (intervention) will then be assessed to evaluate its impact on the care and clinical outcome of the patients.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Stroke
Keywords
Stroke, Ischemic stroke, hemorrhagic stroke, stroke package

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
A before and after, effectiveness-implementation hybrid study design with blinded outcome assessment will be conducted. This type 1 effectiveness-implementation hybrid design will test the essential acute stroke care management plan and secondarily gather data to inform subsequent research trials
Masking
Outcomes Assessor
Masking Description
The clinical outcome will be assessed by a blinded assessor
Allocation
Non-Randomized
Enrollment
300 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Usual Care
Arm Type
No Intervention
Arm Description
Usual care to be provided to patients as per hospital guidelines for 3 months
Arm Title
Intervention arm
Arm Type
Other
Arm Description
The intervention consists of training and education of the site staff about the treatment protocol for the different components of the management plan will be provided on two occasions. This intervention will run for 3 months. Refresher training will be given monthly during the intervention.
Intervention Type
Other
Intervention Name(s)
Acute stroke care Intervention arm
Intervention Description
Training and education of the site staff about the treatment protocol for the different components of the management plan will be provided on two occasions. The aim of these sessions will be to educate stroke champions and other site staff on the management protocols. Available training resources will be accessed (including online materials) and simulation training will be used. New skills such as dysphagia assessment will be emphasized based on existing knowledge and competencies. After training, staff will have another assessment (Post-test) in order to determine whether they have been adequately trained and are able to adhere to the essential acute stroke care management plan. A standardised Power Point presentation and accompanying handouts will be made available for further use in the ward. Refresher training will be provided monthly during the intervention.
Primary Outcome Measure Information:
Title
Adherence
Description
Primary Outcome Measure: Adherence to the predefined components of the essential acute stroke care management plan Adherence will be expressed as all or none measure and is defined as the proportion of patients who receive all the components of acute stroke care management for which the patient is eligible. Adherence will also be expressed as a composite measure, which is defined as the total number of eligible components performed divided by the total number of components for which the patient was eligible.
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Death or disability
Description
Death or disability as measured by Modified Rankin Scale (mRS) at 30 days. The mRS is a disability scale that ranges from 0 (no symptoms) to 6 (death).
Time Frame
30 Days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Adults (age ≥18 years) A clinical or imaging-based diagnosis of acute stroke (ischemic or haemorrhagic) within 72 hours of stroke symptom onset Provision of written informed consent Subjects in observational, natural history and/or epidemiological studies not involving an intervention are eligible. Exclusion Criteria: Patients who have undergone intravenous thrombolysis or mechanical thrombectomy Patients who are planned for transfer to the intensive care unit Subarachnoid haemorrhage Participation in an interventional medical investigation or clinical trial currently or within the past 3 months.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Cheryl Carcel, Dr
Phone
+61 2 8052 4508
Email
ccarcel@georgeinstitute.org.au
First Name & Middle Initial & Last Name or Official Title & Degree
Rebecca Anderson
Email
randerson@georgeinstitute.org.au
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carlos Abanto, Dr
Organizational Affiliation
National Institute of Neurological Sciences, Lima, Peru
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Kolawawole Wahab, Professor
Organizational Affiliation
University of Ilorin & University of Ilorin Teaching Hospital Ilorin, Nigeria
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Hasan Farhan, Professor
Organizational Affiliation
President of Iraqi Scientific Council of Cardiology,Iraq
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Yi Sui, Dr
Organizational Affiliation
Shenyang First People's Hospital Hospital Affiliated Brain Hospital
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Saima Hilal, A/Professor
Organizational Affiliation
National University of Singapore
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Lily Song, Dr
Organizational Affiliation
The George Institute of Global Health, China
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Craig Anderson, Professor
Organizational Affiliation
Executive Director The George Institute for Global Health - China
Official's Role
Principal Investigator
Facility Information:
Facility Name
Murtala Muhammad Specialist Hospital
City
Kano
State/Province
Kano State
ZIP/Postal Code
3200
Country
Nigeria
Facility Name
Federal Medical Centre
City
Lokoja
State/Province
Kogi State
ZIP/Postal Code
1001
Country
Nigeria
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Dr Babatunde Ademiluyi, Dr
Facility Name
Hospital de Apoyo II-2 Sullana
City
Piura
Country
Peru
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alan Gutierrez Nuñez, Dr
Facility Name
Hospital de la Amistad Peru Corea Santa Rosa II-2
City
Piura
Country
Peru
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Genaro Ipanaqué Chiroque, Dr

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
Requests for access to the de-identified data that underlie the study results should be made to: datasharing@georgeinstitute.org. We will provide data to researchers with a methodologically sound proposal, and will work with interested parties to define and operationalise a data access agreement.
IPD Sharing Time Frame
Data will be available after publication of the main paper

Learn more about this trial

Essential Acute Stroke Care in Low Resource Settings: a Pilot studY

We'll reach out to this number within 24 hrs